Related articles / Collections etc.

会員・医療関係の皆さまへ>学会について>ガイドライン・刊行物>Related articles / Collections etc.

Clinical Practice Guidelines for G-CSF

G-CSF適正使用ガイドライン 2022年10月改訂 第2版

Clinical Practice Guidelines for the Use of G-CSF 2022 and related articles(IJCO Collection)

https://link.springer.com/collections/bacajbagja

Japanese Clinical Practice Guidelines for Gastrointestinal Stromal Tumors (GIST)

GIST診療ガイドライン2022年4月改訂第4版

English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology

https://link.springer.com/article/10.1007/s10147-024-02488-1

Clinical Practice Guidelines for Fertility Preservation in Childhood, Adolescent, and Young Adult Cancer Patients

小児，思春期・若年がん患者の妊孕性温存に関する診療ガイドライン 2017年版

Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1

https://link.springer.com/article/10.1007/s10147-021-02081-w　

Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2

https://link.springer.com/article/10.1007/s10147-021-02076-7

Clinical Practice Guidelines for Antiemesis

Clinical Practice Guidelines for Antiemesis 2023 and related articles(IJCO Collection)

https://link.springer.com/collections/ffaijjjife

Clinical Practice Guidelines for the Management of Kidney Injury During Anticancer Drug Therapy

がん薬物療法時の腎障害診療ガイドライン2022

Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022

https://link.springer.com/article/10.1007/s10157-023-02415-0

Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022

https://link.springer.com/article/10.1007/s10147-023-02372-4

Chapter 2:indications and dosing of anticancer drug therapy in patients with impaired kidney function, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022

https://link.springer.com/article/10.1007/s10147-023-02377-z

Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022

https://link.springer.com/article/10.1007/s10147-023-02382-2

Chapter 4: CKD treatment in cancer survivors, from Clinical Practice Guidelines for the Management of Kidney Injury During Anticancer Drug Therapy 2022

https://link.springer.com/article/10.1007/s10147-023-02375-1

Clinical Practice Guidelines of Cancer Drug Therapies for the Elderly

高齢者のがん薬物療法ガイドライン

Clinical Practice Guidelines for Tumor-Agnostic Treatments in Adults and Pediatric Patients with Advanced Solid Tumors toward Precision

成人・小児進行固形がんにおける臓器横断的ゲノム診療のガイドライン第3版

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors

https://link.springer.com/article/10.1007/s10147-023-02360-8

Japanese Society of Clinical Oncology Position Paper on Appropriate Clinical Use of Molecular Residual Disease(MRD)Testing

paper to be prepared

Cancer Treatment Guidance Based on Gene Panel Testing Using Next-Generation Sequencers

Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)

https://link.springer.com/article/10.1007/s10147-020-01831-6
  • がん診療ガイドライン
  • 学術集会抄録アーカイブサイト